NM_130466.4:c.*686T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_130466.4(UBE3B):​c.*686T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.571 in 152,116 control chromosomes in the GnomAD database, including 25,877 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 25867 hom., cov: 33)
Exomes 𝑓: 0.50 ( 10 hom. )

Consequence

UBE3B
NM_130466.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.265

Publications

19 publications found
Variant links:
Genes affected
UBE3B (HGNC:13478): (ubiquitin protein ligase E3B) The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin-protein ligases. This gene encodes a member of the E3 ubiquitin-conjugating enzyme family which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme and transfers the ubiquitin to the targeted substrates. A HECT (homology to E6-AP C-terminus) domain in the C-terminus of the longer isoform of this protein is the catalytic site of ubiquitin transfer and forms a complex with E2 conjugases. Shorter isoforms of this protein which lack the C-terminal HECT domain are therefore unlikely to bind E2 enzymes. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2012]
UBE3B Gene-Disease associations (from GenCC):
  • oculocerebrofacial syndrome, Kaufman type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, G2P, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.729 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UBE3BNM_130466.4 linkc.*686T>C 3_prime_UTR_variant Exon 28 of 28 ENST00000342494.8 NP_569733.2 Q7Z3V4-1A0A024RBI2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UBE3BENST00000342494.8 linkc.*686T>C 3_prime_UTR_variant Exon 28 of 28 1 NM_130466.4 ENSP00000340596.3 Q7Z3V4-1
UBE3BENST00000434735.6 linkc.*686T>C 3_prime_UTR_variant Exon 28 of 28 1 ENSP00000391529.2 Q7Z3V4-1

Frequencies

GnomAD3 genomes
AF:
0.571
AC:
86684
AN:
151932
Hom.:
25818
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.735
Gnomad AMI
AF:
0.587
Gnomad AMR
AF:
0.504
Gnomad ASJ
AF:
0.533
Gnomad EAS
AF:
0.298
Gnomad SAS
AF:
0.389
Gnomad FIN
AF:
0.465
Gnomad MID
AF:
0.563
Gnomad NFE
AF:
0.537
Gnomad OTH
AF:
0.583
GnomAD4 exome
AF:
0.500
AC:
33
AN:
66
Hom.:
10
Cov.:
0
AF XY:
0.500
AC XY:
22
AN XY:
44
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.500
AC:
1
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AF:
1.00
AC:
2
AN:
2
European-Finnish (FIN)
AF:
0.500
AC:
2
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
26
AN:
52
Other (OTH)
AF:
0.500
AC:
2
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.571
AC:
86797
AN:
152050
Hom.:
25867
Cov.:
33
AF XY:
0.561
AC XY:
41707
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.736
AC:
30552
AN:
41526
American (AMR)
AF:
0.504
AC:
7693
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.533
AC:
1848
AN:
3468
East Asian (EAS)
AF:
0.298
AC:
1534
AN:
5146
South Asian (SAS)
AF:
0.389
AC:
1873
AN:
4820
European-Finnish (FIN)
AF:
0.465
AC:
4914
AN:
10578
Middle Eastern (MID)
AF:
0.554
AC:
163
AN:
294
European-Non Finnish (NFE)
AF:
0.537
AC:
36457
AN:
67936
Other (OTH)
AF:
0.584
AC:
1228
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1881
3762
5642
7523
9404
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.568
Hom.:
33947
Bravo
AF:
0.584
Asia WGS
AF:
0.387
AC:
1344
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.9
DANN
Benign
0.45
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2058807; hg19: chr12-109973273; API